Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer.
about
Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes?Adenovirus-mediated gene transfer of interleukin-4 into pancreatic stellate cells promotes interleukin-10 expressionDisruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type I diabetes.The humanized NOD/SCID mouse as a preclinical model to study the fate of encapsulated human isletsAnticytokine gene therapy of autoimmune diseases.Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases.Cytokines in immunotherapy of experimental uveitis.Antigen-based immune modulation: DNA vectors and beyond.Hepatic insulin gene therapy in insulin-dependent diabetes mellitus.Antigen-specific induction of regulatory T cells for type 1 diabetes therapy.Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD miceHuman and rodent pancreatic beta-cells express IL-4 receptors and IL-4 protects against beta-cell apoptosis by activation of the PI3K and JAK/STAT pathways.Pre-incubation with interleukin-4 mediates a direct protective effect against the loss of pancreatic beta-cell viability induced by proinflammatory cytokines.Interleukin-10 plasmid construction and delivery for the prevention of type 1 diabetes.Peripheral blood mononuclear cells of patients with latent autoimmune diabetes secrete higher levels of pro- & anti-inflammatory cytokines compared to those with type-1 diabetes mellitus following in vitro stimulation with β-cell autoantigens.Interleukin-4-expressing plasmid DNA inhibits reovirus type-2-triggered autoimmune insulitis in DBA/1 J suckling mice.
P2860
Q26739691-25C17560-DF15-47B9-9324-E35FDF335BF6Q28573629-84114F34-D4A7-425C-95BD-27BF07DD8417Q33784518-CB0AD691-45E6-477C-9982-4BF0ADEE3DFEQ34072336-A9067A56-CA20-4354-BED0-CAB41A21FA28Q34451949-E9B9FA7D-DD9F-4B7A-956F-954172C4CF4DQ34706913-42B17523-7823-4A32-9364-710685821A96Q34731064-7FAF34EA-A05D-42C5-A1A2-CD2B4F2CF0F4Q34993224-12900444-89DB-4A08-A299-85FB6249BA2CQ35040861-99CB0DB6-C29A-49EB-B8AA-5EA1B02B2FC1Q35544053-92F36FAD-7DCF-4936-8E93-A237420F5AB7Q36327362-4087E33D-02E0-4B42-9564-ADEDA8A9075FQ36755359-D5FAEC1D-D9B0-4CDD-9BD2-2C18A00D6417Q39837309-881F324D-7527-4931-A014-CCB28274DD27Q40150910-4D3D1957-E661-4A28-8F7F-CB223AB80DDAQ40203823-BF7C545B-04B3-4496-A59B-9177693FA623Q44096650-0139128A-CA67-450E-882B-F40260064AF9Q44474592-D620283C-18B0-410E-9E11-6A112F5AEC2B
P2860
Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Immunotherapy of spontaneous t ...... vector-mediated gene transfer.
@en
Immunotherapy of spontaneous t ...... vector-mediated gene transfer.
@nl
type
label
Immunotherapy of spontaneous t ...... vector-mediated gene transfer.
@en
Immunotherapy of spontaneous t ...... vector-mediated gene transfer.
@nl
prefLabel
Immunotherapy of spontaneous t ...... vector-mediated gene transfer.
@en
Immunotherapy of spontaneous t ...... vector-mediated gene transfer.
@nl
P2093
P2860
P921
P356
P1433
P1476
Immunotherapy of spontaneous t ...... vector-mediated gene transfer.
@en
P2093
Arreaza GA
Cameron MJ
Delovitch TL
Waldhauser L
P2860
P2888
P304
P356
10.1038/SJ.GT.3301309
P577
2000-11-01T00:00:00Z
P5875
P6179
1008438519